[1]
R. Nade, E. Tannoury, T. Rizk, and H. . Ghanem, “Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors”, Autops. Case Rep., vol. 11, p. e2021261, Apr. 2021, doi: 10.4322/acr.2021.261.